Glakolens
Italy, IT · 1 known investors
GlakoLens develops a smart contact lens that monitors intraocular pressure fluctuations over extended periods to help ophthalmologists diagnose and treat glaucoma more accurately. The device enables 24-hour IOP monitoring for earlier detection of the chronic eye disease that is the second leading cause of blindness globally.
AI & Machine LearningHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Glakolens do?
- GlakoLens develops a smart contact lens that monitors intraocular pressure fluctuations over extended periods to help ophthalmologists diagnose and treat glaucoma more accurately. The device enables 24-hour IOP monitoring for earlier detection of the chronic eye disease that is the second leading cause of blindness globally.
- Who are Glakolens's investors?
- Glakolens's investors include ACT Venture Partners.
- Where is Glakolens headquartered?
- Glakolens is headquartered in Italy, IT.